Management of frontotemporal dementia: targeting symptom management in such a heterogeneous disease requires a wide range of therapeutic options
There are no US FDA-approved therapies for the management of frontotemporal dementia (FTD). Evidence-based medicine that would support a FDA indication for the treatment of FTD requires large-scale, r
Management of frontotemporal dementia: targeting symptom management in such a he...